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Abstract UbcH2 encodes a human ubiquitin conjugating en- 
zyme (E2) able to conjugate ubiquitin to histone H2A in an E3 
independent manner in vitro, which indicates that UbcH2 directly 
interacts with its substrates. To identify parts of the enzyme that 
are capable of binding H2A, we expressed several deletion mu- 
tants of UbcH2 in E. coli and tested the ability of the affinity 
purified mutant proteins to ubiquitinate H2A in the presence of 
bacterial expressed E1 and ubiquitin. With this in vitro assay we 
identified a C-terminal part of UbcH2 to be important for the 
interaction with H2A. Transfer of this C-terminal domain to 
another human E2, which is unable to catalyze ubiquitination of 
histories, leads to a fully active hybrid human ubiquitin conjugat- 
ing enzyme capable of H2A ubiquitination. These results demon- 
strate that UbcH2 consists of two functionally independent do- 
mains. A N-terminal core domain with ubiquitin conjugating ac- 
tivity, and a C-terminal domain which interacts with substrate 
proteins. 
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1. Introduction 
}enetic studies in yeast revealed that ubiquitin conjugation 
is r zsponsible for many different cellular functions, such as cell 
cytle progression and regulation [1,2], DNA repair, sporulation 
[3]. heat shock and cadmium resistance [4,5] and peroxisome 
bk~genesis [6]. 
~ttachment of the highly conserved protein ubiquitin to 
otl~er eukaryotic proteins targets them for selective degrada- 
tioa. Substrate specific ubiquitin conjugating enzymes (E2 en- 
zyvaes) and accessory factors recognize specific signals on sub- 
strates and attach ubiquitin to specific lysine residues, which 
tri~:gers their degradation by the proteolytic pathway (for re- 
vie'us see [7-9]). Substrate specificity of the ubiquitin conjugat- 
in~ system is mediated by different E2 enzymes and accessory 
factors known as ubiquitin ligases (E3 enzymes). 
variety of in vivo substrates of the ubiquitin conjugating 
system have been identified, including histones [10], actin [11], 
cytlins [12], the tumor suppressor p53 [13,14], MATch2 tran- 
scr ption repressor [15], cell surface receptors [16-18], c-jun [19] 
and NF~cB [20]. 
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Some ubiquitin conjugating enzymes are able to transfer 
ubiquitin to the model substrate histone in vitro without any 
accessory factors, such as E3s. Among these E2s are yeast 
RAD6/UBC2 [3] and CDC34/UBC3 [1]. We have recently iso- 
lated a human ubiquitin conjugating enzyme, UbcH2 and its 
putative yeast homologue UBC8 and demonstrated their E3 
independent ability to ubiquitinate histone H2A in vitro [21]. 
However, the cellular functions and in vivo substrates of UBC8 
and UbcH2 remain unclear, since ubc8 deletion mutants show 
no obvious phenotype [22]. In this communication we report 
the functional analysis of mutant UbcH2 proteins and human 
hybrid ubiquitin conjugating enzymes. Our data suggest hat 
UbcH2 consists of two functionally independent domains, an 
N-terminal part with basic ubiquitin conjugation functions, and 
a C-terminal domain which interacts with substrates. 
2. Experimental 
2.1. Construction of expression plasmids 
All constructs were cloned into the unique Stul site of pMALVM-p 
(New England Biolabs). For expression as 6 x His tagged proteins the 
inserts were cut out from pMALTM-p with BamHI and HindIII and 
ligated into the expression vector pQ 31 (Quiagene, CA). The following 
oligonucleotides were used in this study to construct the deletion mu- 
tants and hybrid clones. Parts of the oligonucleotides which were used 
to add restriction sites or termination codons are written in italics: O-1: 
ATGTCATCTCCCAGTCCG; 0-2: TAATTAAGCTTCAAGAGCT- 
CTCCGATGAGC (reverse complementary); 0-3: TAATTAAGCTT- 
CACGTGGCGTATTTCTGG (reverse complementary); 0-4: ATG- 
AAGCTCATCGAGAGTAAACATG; 0-5: TAATTAAGCTTCTAC- 
AACTCCATATCC (reverse complementary). 
UbcH2 and UbcH2 deletion constructs: Oligonucleotides O-1 and 
0-2 were used in a standard PCR reaction to amplify UbcH2 lacking 
39 nucleotides at the 3' end (UbcH2A170). The purified PCR fragment 
was rendered blunt ended at its 5' end, digested with HindIII at its 3" 
end and cloned into StuI and HindIII digested pMALTM-p expression 
vector. The resulting clone was cut with BamHI and HindIII and the 
insert was ligated to the expression plasmid pQ 31 cut with the same 
enzymes. Clones in pMALTM-p are expressed as fusion proteins with 
malE, whereas pQ 31 clones get an N-terminal 6x His tag. Exactly the 
same strategy was followed to construct UbcH2A151 (O-1 and 0-3) and 
A15-UbcH2 (0-4 and 0-5). To get UbcH2A128 we used the unique PstI 
site in the coding sequence of UbcH2 and cloned the fragment in 
StuI/PstI cut pMALVM-p. Subsequently a BamHI/PstI fragment was 
ligated in pQ 31. 
Expression and construction of SM1, SM1-C2 and N2-SM1-C2 was 
similar to that of the other constructs. To express recombinant human 
ubiquitin activating enzyme in E. coli, the coding sequence of the 
human El [23] was amplified by the PCR reaction and cloned into the 
expression vector pQ 31. 
2.2. Protein expression and purification 
Protein expression and purification was performed according to 
manufacturer. Recombinant E1 and all E2 constructs were expressed 
as N-terminal 6 x His tagged proteins, and used in the assay after 
affinity purification on Ni-NTA resin (Quiagene, CA). Contaminating 
imidazol was removed by anion exchange chromatography onDEAE- 
cellulose: Proteins were bound to the column in buffer P1 (50 mM 
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Tris-HC1 pH 7.2, 0.2 mM DTT). After washing with 10 column-vol- 
umes buffer P1, proteins were eluted in 50 mM Tris-HCl pH 7.2, 0.2 
mM DTT, 0.5 M KCI. E2s were also expressed asmalE fusion proteins. 
Expression, purification and factor Xa cleavage was performed as de- 
scribed [21]. 
2.3. Thioester formation and histone ubiquitination assays 
Ubiquitin conjugation was performed ina total volume of 25/.tl for 
30 min at 37°C. Reaction conditions were exactly as described [21], 
except that approximately 10ng of recombinant human El was used 
to activate ubiquitin. Proteins were separated on 12.5% or 15% SDS- 
PAGE prior to their transfer to a nitrocellulose membrane. Detection 
of biotinylated ubiquitin by strepavidin-alkaline phosphatase conju- 
gates was according to the procedure described in[21]. To detect thio- 
esters between E2s and ubiquitin samples were not reduced prior to 
electrophoreses. 
To assay histone ubiquitination 1/lg bovine histone H2A (Boehrin- 
get Mannheim) was added to the thioester reaction mixture followed 
by a 30 min incubation at 37°C. Samples were boiled in the presence 
of 100 mM DTT for 5 min prior to electrophoreses to break thiolester 
linkage between E2 and ubiquitin. 
3. Resu l ts  and d iscuss ion  
We have recently isolated the human ubiquitin conjugating 
enzyme UbcH2 and demonstrated its ability to ubiquitinate 
histone H2A in vitro [21]. This reaction isindependent from any 
accessory proteins uch as ubiquitin ligases (E3s) and therefore 
requires direct interaction between the UbcH2 protein and the 
substrate molecules (H2A). Because UbcH2 shows high homol- 
ogy to all other ubiquitin conjugating enzymes in the core 
domain surrounding the active cystein, we predicted that the 
C-terminal and the N-terminal regions of the protein would be 
responsible for interaction with substrates. 
To analyze the function of the N- and C-termini in substrate 
binding, we constructed several mutated UbcH2 proteins lack- 
ing either 15 N-terminal amino acids or different parts of the 
C-terminus (Fig. 1). Proteins were expressed in E. coli either as 
a fusion with the maltose binding protein or with an N-terminal 
6 x His tag. Because the malE fusions turned out to be inactive, 
male was removed by factor Xa cleavage [21]. In general, the 
6 × His tag reduces the thioester formation activity compared 
to factor Xa cleaved malE-UbcH2 fusion protein, therefore 
higher amounts of the 6 x His-tagged proteins were used in the 
assays. 
For ubiquitin activation we used bacterial expressed 6 x His 
tagged human ubiquitin activating enzyme (El) purified on 
Ni-NTA resin. We found the recombinant E1 to be a very 
convenient source of human El, because it is easy to purify in 
considerable amounts without contamination byE2 activities, 
which are often found in E1 preparations purified from human 
placenta. 
Prior to examining H2A ubiquitination we checked the abil- 
ity of the mutant proteins to accept activated ubiquitin from E 1 
by forming a thioester conjugate with ubiquitin. 
Successive deletion of sequences from the C-terminal part of 
UbcH2 leads to proteins which are fully active in terms of 
thioester formation providing the deletion does not exceed 
amino acids 151 (Fig. 2a). Sequences between amino acid 128 
and 151 are absolutely required for thioester formation (com- 
pare Fig. 2a, lanes 3 and 4). These 23 amino acids may be 
involved in the interaction with E1 and/or ubiquitin. Alterna- 
tively the conformation of UbcH2A128 could be changed so 
that the active cystein is hidden. However, deletion of the last 
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Fig. 1. Expression constructs. For cloning strategies see section 2. The 
constructs were analysed for thioester formation activity and histone 
ubiquitination. Detectable (+) or not detectable (-) activity of the 
particular constructs i indicated. 
32 amino acids of UbcH2 (UbcH2A151) has no effect on thio- 
ester formation (Fig. 2a). 
On the other hand, deletion of the first 15 N-terminal amino 
acids (A15-UbcH2) abolishes thioester formation (data not 
shown). This is surprising because a very similar truncation of 
the yeast homolog UBC8 does not affect formation of thioester 
bonds between UBC8 and ubiquitin [22]. 
We were interested in whether the C-terminal deletions of 
UbcH2 have any influence on histone ubiquitination. In our 
assay biotinylated ubiquitin isactivated by recombinant human 
E1 and is transferred to bovine histone H2A by E2 enzymes. 
After Western blotting biotinylated ubiquitin is detected by 
avidin-alkaline phosphatase conjugates. Because samples were 
boiled in the presence of DTT prior to their separation on 
SDS-PAGE, which breaks thioester bonds between El-ubiq- 
uitin and E2-ubiquitin, the stable H2A-ubiquitin conjugates 
can easily be detected. 
We found that deletion of 13 C-terminal amino acids of 
UbcH2 (UbcH2A170) does not affect its ability to ubiquitinate 
H2A in vitro, while deletion of additional 19 amino acids 
(UbcH2A151) abolishes histone ubiquitination activity com- 
pletely. Of course, UbcH2A128 which failed to form thioester 
adducts with ubiquitin, cannot catalyze ubiquitination f H2A 
(Fig. 2b). Taken together, these results suggest hat the C- 
terminal region between amino acids 151 and 170 of UbcH2 is 
necessary for substrate binding. Interestingly, in vitro studies 
with yeast UBC2/RAD6 revealed that truncation of its C-termi- 
nus affects its ability to polyubiquitinate histones but does not 
affect thioester formation [24]. Moreover, it was shown that the 
C-terminus of UBC2/RAD6 is required for sporulation but not 
for the DNA repair functions of UBC2/RAD6 [25]. The human 
RAD6 homologue UbcH1 [26] which lacks comparable C-ter- 
minal extensions complements he repair defect of rad6 mu- 
tants but not the sporulation deficiency [27,28]. 
The question arises, whether the C-terminal part of UbcH2 
is sufficient for interaction with H2A, or if there are other 
sequences within UbcH2 which are required for substrate bind- 
ing. To address this question we constructed hybrid human 
ubiquitin conjugating enzymes (Fig. l) and tested their ability 
to ubiquitinate histone H2A. The hybrid E2s consist of catalytic 
inactive N- and C-terminal parts of UbcH2 and an active enzy- 
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Fi~. 2. Thioester formation and histone ubiquitination activities of UbcH2 deletion mutants. (1) UbcH2, (2) UbcH2A170, (3) UbcH2A151, 
(4) UbcH2A128. (a) Thioester formation of UbcH2 and deletion mutants: amples were not reduced prior to electrophoreses. Bands corresponding 
to • he UbcH2-, UbcH2A 170- and UbcH2A 151-ubiquitin conjugates (E2 ~ Ub) could not be detected when thioesters were broken by boiling the samples 
fo] 5 min in the presence of 100 mM DTT (data not shown). Because of the low amount of El used the thioester between E1 and ubiquitin was not 
delectable. E2~Ub indicates thioester conjugates and Ub indicates free biotinylated ubiquitin. (b) Histone ubiquitination: reactions contained 1/lg 
bo 'ine histone H2A (Boehringer Mannheim). Samples were boiled in the presence of 100 mM DTT for 5 rain to break thiolester linkage between 
E2 and ubiquitin. H2A-Ub marks ubiquitinated histone H2A. The star indicates a contaminating protein in the ubiquitin preparations u ed for 
bit tinylation. 
m~ tic part, which is able to form thioester linkage with ubiq- 
ui~ in, but lacks histone ubiquitinating function. This enzymatic 
fu~Lction was fulfilled by SM1, a human ubiquitin conjugating 
en-yme recently isolated in our lab [29]. The entire coding 
se~!uence of SM 1 was fused to the C-terminal region of UbcH2 
(amino acids 152 to 183) which resulted in the hybrid molecule 
SM1-C2 (C2 = C-terminus UbcH2) (Fig. 1). Analysis of the 
roie of N-terminal sequences in UbcH2 in H2A ubiquitination 
w~is hampered by the loss of ubiquitin conjugation activity 
upon deletion of the 15 N-terminal residues. Therefore we con- 
stJ acted the hybrid molecule N2-SM1-C2 (N2 -- N-terminus of 
Ut~cH2) to test the influence of UbcH2's N-terminus on H2A 
ubiquitination. I  N2-SM1-C2 the 29 amino terminal residues 
of SM l-C2 were replaced by the first 30 amino acids of UbcH2 
(1: g. 1). 
]ince SM1 and the two hybrid ubiquitin constructs (SM1-C2 
and N2-SM1-C2) are able to form thioester bonds with ubiq- 
ui~in in our in vitro assay (data not shown), we can compare 
th,'ir histone ubiquitination activities. 
ks shown in Fig. 3, SM1 itself is unable to catalyze H2A 
ubiquitination, which is consistent with previous results [30]. 
H, ,wever, fusion of 32 C-terminal amino acids of UbeH2 to the 
enlire coding sequence of SM1 (SM1-C2) alters the substrate 
recognition properties of SM 1, such that it gains the ability to 
ubiquitinate H2A. On the other hand replacement of the N- 
telminal part of SMI with the 30 first residues of UbcH2 has 
no influence on histone H2A ubiquitination. Although, com- 
parison of lanes 2 and 3 in Fig. 3 might suggest slightly different 
activities of SM1-C2 and N2-SM1-C2, we attribute that to 
difficulties with quantitative r producible histone transfer to 
nitrocellulose. 
The results from the experiments with the hybrid constructs 
are consistent with the results with UbcH2 deletion mutants 
described above. Our data suggest that UbcH2 consists of two 
separated omains with independent functions. Domain I ex- 
tends to a region around amino acid 150 and functions as a 
ubiquitin conjugating enzyme. Domain II consists of sequences 
starting around amino acid 150 mediates interaction with sub- 
strates. This substrate recognition function of domain II is 
similar to that performed by E3 enzymes in E3 dependent 
ubiquitination reactions. UbcH2 therefore seems to contain a 
combination of E2 and E3 enzymes in a single polypeptide 
chain with a N-terminal E2-domain and a C-terminal 'E3-1ike' 
part. 
The two domain structure UbcH2 can be compared with the 
yeast ubiquitin conjugating enzyme UBC3/CDC34. In an ele- 
gant experiment the C-terminal (substrate binding) domain was 
fused to the catalytic domain of yeast UBC2/RAD6. Subse- 
quently it was demonstrated that this hybrid molecule with 
ubiquitin conjugating activity resulting from the RAD6 portion 
and substrate recognition conferred by the CDC34 part is able 
to rescue cdc34 mutants [31,32]. 
196 P Kaiser et al./FEBS Letters 377 (1995) 193-196 
1 2 3 
H2A-Ub 
Ub 
Fig. 3. Histone ubiquitination abilities of UbcH2-SM1 hybrids. (1) 
SM1, (2) SM1-C2, (3) N2-SM1-C2. Ub: free biotinylated ubiquitin. 
H2A-Ub: ubiquitinated histone H2A. The star marks a contaminating 
protein in ubiquitin preparations u ed for biotinylation. 
No phenotype has yet been described for the deletion of the 
yeast UbcH2 homologue UBC8. This makes us unable to test 
the UbcH2-SM 1 hybrid ubiquitin conjugating enzymes in com- 
plementation experiments to demonstrate the biological rele- 
vance of the in vitro experiments described above. But our 
results can help to design experiments which use the C-terminal 
substrate binding part to screen for interacting proteins (sub- 
strates) or use it in dominant negative strategies in the search 
for the biological role of UbcH2. 
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